Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?

  • Domenico D’Amico
  • Susanna Usai
  • Luigi Caputi
  • Gennaro Bussone
Migraine and Interatrial Septum Anomalies


Patent foramen ovale (PFO) is associated with ischaemic stroke and migraine with aura (MA), and has been proposed as a cause of both. Numerous studies indicate that percutaneous PFO closure can improve MA, but they all suffer from methodological problems. It is recommended that the advantages and risks of PFO closure be carefully assessed in each individual, bearing in mind that effective prophylactic medications are available for MA patients with high attack frequency.


Patent foramen ovale (PFO) Ischaemic stroke Migraine with aura (MA) Percutaneous closure 


  1. 1.
    Henrich JB, Horwitz RI (1989) A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 42:773–780PubMedCrossRefGoogle Scholar
  2. 2.
    Tzourio C, Iglesias S, Hubert JB et al (1993) Migraine and risk of ischaemic stroke: a case-control study. Br Med J 307:289–292CrossRefGoogle Scholar
  3. 3.
    Marini C, Carolei A, Roberts RS et al (1993) Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology 12:70–81PubMedCrossRefGoogle Scholar
  4. 4.
    Tzourio C, Tehindrazanarivelo A, Iglesias S et al (1995) Casecontrol study of migraine and risk of ischaemic stroke in young women. Br Med J 310:830–833Google Scholar
  5. 5.
    Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347:1503–1506PubMedGoogle Scholar
  6. 6.
    Chang CL, Donaghy M, Poulter N, The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1999) Migraine and stroke in young women: case-control study. Br Med J 318:13–18Google Scholar
  7. 7.
    Donaghy M, Chang CL, Poulter N (2002) Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 73:747–750PubMedCrossRefGoogle Scholar
  8. 8.
    Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Br Med J 330:63CrossRefGoogle Scholar
  9. 9.
    Kurth T, Slomke MA, Kase CS et al (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64:1020–1102PubMedGoogle Scholar
  10. 10.
    Stang PE, Carson AP, Rose KM et al (2005) Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 64:1573–1577PubMedCrossRefGoogle Scholar
  11. 11.
    Becker C, Brobert GP, Almqvist PM et al (2007) Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache 47:1374–1384PubMedGoogle Scholar
  12. 12.
    Overell JR, Bone I, Less KR (2000) Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology 55:1172–1179PubMedGoogle Scholar
  13. 13.
    Amarenco P (2005) Patent foramen ovale and the risk of stroke: smoking gun guilty by association? Heart 91:441–443PubMedCrossRefGoogle Scholar
  14. 14.
    Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262–2268PubMedCrossRefGoogle Scholar
  15. 15.
    Homma S, Sacco RL, DiTullio MR et al for PICSS Investigators (2202) Effect of medical treatment in stroke patients with patent foramen ovale. Circulation 105:2625–2631Google Scholar
  16. 16.
    Del Sette M, Angeli S, Leandri M et al (1998) Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 8:327–330PubMedCrossRefGoogle Scholar
  17. 17.
    Anzola GP, Magoni M, Guindani M et al (1999) Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52:1622–1625PubMedGoogle Scholar
  18. 18.
    Wilmshurst P, Nightingale S. Walsh KP, Morrison WL (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648–1651PubMedCrossRefGoogle Scholar
  19. 19.
    Dalla Volta G, Guindani M, Zavarise P et al (2005) Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 6:328–330PubMedCrossRefGoogle Scholar
  20. 20.
    Schwerzmann M, Nedeltchev K, Lagger F et al (2005) Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65:1415–1418PubMedCrossRefGoogle Scholar
  21. 21.
    Carod-Artal FJ, da Silveira Ribeiro L, Braga H et al (2006) Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26:934–939PubMedCrossRefGoogle Scholar
  22. 22.
    Domitrz I, Mieszkowski J, Kaminska A (2007) Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache 47:1311–1318PubMedCrossRefGoogle Scholar
  23. 23.
    Anzola GP, Meneghetti G, Zanferrari C et al; the SaM Study Group (2008) Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia 28:360–366PubMedCrossRefGoogle Scholar
  24. 24.
    Morandi E, Anzola GP, Angeli S et al (2003) Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 16:39–42PubMedCrossRefGoogle Scholar
  25. 25.
    Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648–1651PubMedCrossRefGoogle Scholar
  26. 26.
    Schwerzmann M, Wiher S, Nedeltchev K et al (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62:1399–1401PubMedGoogle Scholar
  27. 27.
    Post M, Thijs V, Herroelen L, Budts W (2004) Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 62:1439–1440PubMedGoogle Scholar
  28. 28.
    Reisman M, Christofferson RD, Jesurum J et al (2005) Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45:493–495PubMedCrossRefGoogle Scholar
  29. 29.
    Azarbal B, Tobis J, Suh W et al (2005) Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 45:489–492PubMedCrossRefGoogle Scholar
  30. 30.
    Giardini A, Donti A, Formigari R et al (2006) Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 67:625–629PubMedCrossRefGoogle Scholar
  31. 31.
    Anzola GP, Frisoni GB, Morandi E et al (2006) Shunt-associated migraine response favorably to atrial septal repair: a case-control study. Stroke 37:430–434PubMedCrossRefGoogle Scholar
  32. 32.
    Dowson A, Mullen MJ, Peatfield R et al (2008) Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117:1397–1404PubMedCrossRefGoogle Scholar
  33. 33.
    Dubiel M, Bruch L, Schmehl I et al (2008) Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 21:32–37PubMedCrossRefGoogle Scholar
  34. 34.
    Jesurum JT, Fuller CJ, Velez CA et al (2007) Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics. J Headache Pain 8:209–216PubMedCrossRefGoogle Scholar
  35. 35.
    Giardini A, Donti A, Formigari R et al (2006) Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 151:922–925PubMedCrossRefGoogle Scholar
  36. 36.
    Anzola GP, Morandi E, Casilli F, Onorato E (2006) Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 66:765–767PubMedCrossRefGoogle Scholar
  37. 37.
    Meissner I, Khandheira BK, Heit JA et al (2006) Patent foramen ovale; innocent or guilty? J Am Coll Cardiol 47:440–445PubMedCrossRefGoogle Scholar
  38. 38.
    Di Tullio MR, Sacco RL, Sciacca RR et al (2007) Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49:797–802PubMedCrossRefGoogle Scholar
  39. 39.
    Mas JL, Arquizan C, Lamy C et al (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740–1746PubMedCrossRefGoogle Scholar
  40. 40.
    De Castro S, Cartoni D, Fiorelli M et al (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31:2407–2413PubMedGoogle Scholar
  41. 41.
    Kimmelstiel C, Gange C, Thaler D (2007) Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv 69:740–746PubMedCrossRefGoogle Scholar
  42. 42.
    Buring JE, Peto R, Hennekens CH (1990) Low-dose aspirin for migraine prophylaxis. JAMA 264:1711–1713PubMedCrossRefGoogle Scholar
  43. 43.
    Diener HC, Hartung E, Chrubasik J et al (2001) A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, doubleblind, parallel group phase III study. Cephalalgia 21:120–128PubMedCrossRefGoogle Scholar
  44. 44.
    Bensenor IM, Cook NR, Lee IM et al (2001) Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 21:175–183PubMedCrossRefGoogle Scholar
  45. 45.
    Sharifi M, Burks J (2004) Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 63:255PubMedCrossRefGoogle Scholar
  46. 46.
    Cologno D, Torelli P, Cademartiri C, Manzoni GC (2000) A prospective study of migraine with aura attacks in a headache clinic population. Cephalalgia 20:925–930PubMedCrossRefGoogle Scholar
  47. 47.
    Silberstein SD for the US Headache Consortium (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754–762PubMedGoogle Scholar
  48. 48.
    Evers S, Afra J, Frese A, Goadsby PJ et al (2006) EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol 13:560–572PubMedCrossRefGoogle Scholar
  49. 49.
    D’Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19:64–66PubMedCrossRefGoogle Scholar
  50. 50.
    Pascual J, Caminero AB, Mateos V et al (2004) Preventing disturbing migraine aura with lamotrigine: an open study. Headache 44:1024–1028PubMedCrossRefGoogle Scholar
  51. 51.
    Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730–1732PubMedCrossRefGoogle Scholar
  52. 52.
    De Simone R, Marano E, Di Stasio E et al (2005) Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache 45:385–386PubMedCrossRefGoogle Scholar
  53. 53.
    SPREAD-Stroke Prevention And Educational Awareness Diffusion (2007) Ictus cerebrale: Linee Guida Italiane, V edn. 20 DecemberGoogle Scholar
  54. 54.
    Khairy P, O’Donnell C, Landzberg MJ (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. A systematic review. Ann Intern Med 139:753–760PubMedGoogle Scholar
  55. 55.
    Anzola GP, Morandi E, Casilli F, Onorato E (2004) Does transcatheter closure of patent foramen ovale really “shut the door”: a prospective study with transcranial Doppler. Stroke 35:2140–2144PubMedCrossRefGoogle Scholar
  56. 56.
    Egred M, Andron M, Albouaini K et al (2007) Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up. J Interv Cardiol 20:395–401PubMedCrossRefGoogle Scholar
  57. 57.
    Wahl A, Kunz M, Moscovitis A et al (2008) Long-term results after fluoroscopy guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 94:336–341PubMedCrossRefGoogle Scholar
  58. 58.
    Bousser MG (2004) Estrogens, migraine, and stroke. Stroke 35[11 Suppl 1]:2652–2656PubMedCrossRefGoogle Scholar
  59. 59.
    D’Amico D, Moschiano F, Leone M et al (1998) Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 18:618–621PubMedCrossRefGoogle Scholar
  60. 60.
    Giardini A, Donti A, Formigari R et al (2007) Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int J Cardiol 120:357–362PubMedCrossRefGoogle Scholar
  61. 61.
    D’Amico D, Moschiano F, Attanasio A et al (2003) Hyperhomocysteinemia in patients with migraine with aura. Cephalalgia 23:742Google Scholar
  62. 62.
    Kowa H, Yasui K, Takeshima T et al (2000) The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 96:762–764PubMedCrossRefGoogle Scholar
  63. 63.
    Pezzini A, Grassi M, Del Zotto E et al (2007) Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 38:3145–3151PubMedCrossRefGoogle Scholar
  64. 64.
    Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 20:310–319PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Domenico D’Amico
    • 1
  • Susanna Usai
    • 1
  • Luigi Caputi
    • 1
  • Gennaro Bussone
    • 1
  1. 1.Department of Clinical Neurosciences Department“C. Besta” Neurological InstituteMilanItaly

Personalised recommendations